Brief: Shanghai Bio-Heart Biological Technology To Make Capital Increase Of RMB15 Mln Into Shanghai Xinzhi Medical Technology
April 14 (Reuters) - Shanghai Bio-heart Biological
Technology Co Ltd 2185.HK :
* TO MAKE CAPITAL INCREASE OF RMB15 MILLION INTO SHANGHAI
XINZHI
MEDICAL TECHNOLOGY
* UPON COMPLETION, CO'S DIRECT STAKE IN XINZHI MEDICAL
WOULD BE
ABOUT 14.79%
* CAPITAL INCREASE INTO XINZHI MEDICAL IN EXCHANGE FOR
RMB361,144
OF REGISTERED CAPITAL OF XINZHI MEDICAL
Further company coverage: 2185.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Shanghai Bio-heart Biological Technology
See all newsBrief: Shanghai Bio-Heart Biological Technology Says NMPA Approves Bioheart Bioabsorbable Drug-Eluting Stents
Brief: Shanghai Bio-Heart Biological Technology Says Iberis Rdn System Completes Registration In Vietnam
Brief: Shanghai Bio-Heart Biological Technology Says Iberis RDN System Completed Registration In Thailand
Brief: Shanghai Bio-Heart Biological Technology Says Iberis RDN System Completes Registration With MHRA In UK
Brief: Shanghai Bio-Heart Biological Technology's Controlling Shareholder Increases Shareholding